Email this article Clinical experience using selective immunomodulating targeted therapy of Interstitial lymphocytic lung disease in a group of pediatric patients with primary immunodeficiencies - PDF (Russian)
Copyright (c) 2018 «D. Rogachev NMRCPHOI»
This work is licensed under a Creative Commons Attribution 4.0 International License.